Magnetic surgery system aims to reduce incisions in gynecologic procedures
NCT ID NCT06743256
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new magnetic surgical system designed for laparoscopic gynecologic surgeries. The goal was to see if it could safely replace some surgical tools and reduce the number of incisions needed. Only 12 people participated before the study was stopped early.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Levita Magnetic Surgical System (device)
- What this could lead to
- If successful, this device could allow surgeons to perform gynecologic procedures with fewer incisions, potentially reducing pain and recovery time.
- What could go wrong
- The trial was terminated early with only 12 participants, so results are very limited. The device may not work for all patients or procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
12 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Jun 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * At least 18 years of age * Having a BMI of at least 20 kg/m2 * Scheduled to undergo elective gynecological procedure * Willing and able to provide a written Informed Consent Form (ICF) to participate in the study prior to any study required procedures Exclusion Criteria: * Individuals with BMI higher than 60 kg/m2. * Emergency procedures (e.g., ectopic pregnancy, severe bleeding). * Significant comorbidities: e.g. cardiovascular, neuromuscular, chronic obstructive pulmonary disease, and urological disease (renal failure). * Individuals with pacemakers, defibrillators, or other electromedical implants. * Individuals with ferromagnetic implants. * Clinical history of impaired coagulation confirmed by abnormal blood tests. * Anatomical abnormality or disease of intended target tissue noted after initiation of index procedure that would prevent device use. * Pregnant or wishes to become pregnant during the length of study participation. * Individual is not likely to comply with the follow-up evaluation schedule. * Participating in a clinical trial of another investigational drug or device.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gynecological laparoscopic surgery are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Clinico San Borja Arriaran
Peñalolén, Santiago Metropolitan, Chile
-
Hospital Santiago Oriente "Dr. Luis Tisné Brousse"
Peñalolén, Santiago Metropolitan, Chile
More trials for these conditions
Other studies related to the condition(s) this trial covers.